Why is the Polynovo share price powering 6% on Tuesday?

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.

The Polynovo Limited (ASX: PNV) share price is trading higher today amid a major announcement from the company.

Shares of the medical devices company currently trade for $2.135 each, a 5.69% gain. Earlier today, the Polynovo share price hit an intraday high of $2.20 a share, a rise of 9%

Let’s find out why investors are buying Polynovo shares today.

What happened?

Polynovo will receive $500,000 under the Victorian government’s Medtech Manufacturing Capability Program.

The company said it will use the funds to buy and upgrade manufacturing equipment for its Novosorb Synpath products which are used in treating diabetic foot ulcers, among other applications.

Polynovo chair David Williams said:

Our SynPath product offers significant health economic and healing benefits over biologic-based products in the treatment and wound closure of diabetic foot ulcers and venous leg ulcers. The much appreciated government grant will support manufacturing the new product at our Port Melbourne plant from where we will ship to the world.

Polynovo share price snapshot

The Polynovo share price is currently up almost 40% year to date.

The company’s shares are significantly outperforming the S&P/ASX 200 Healthcare Index (ASX: XHJ) which has contracted 3.3% so far in 2022.

Across the broader market, the company is also beating the S&P/ASX 200 Index (ASX: XJO) year to date — it’s down around 6%.

At its current share price, Polynovo has a market capitalisation of around $1.4 billion.

The post <strong>Why is the Polynovo share price powering 6% on Tuesday?</strong> appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Matthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/g9ixJ4o

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *